Inhibition of IκB Kinase-β Protects Dopamine Neurons Against Lipopolysaccharide-Induced Neurotoxicity

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2010-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/jpet.110.165829PMID 20190013PMCID PMC2879929
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impaired Priming and Activation of the Neutrophil NADPH Oxidase in Patients with IRAK4 or NEMO Deficiency1

  2009cited by this paper
• MPTP and SNpc DA neuronal vulnerability: Role of dopamine, superoxide and nitric oxide in neurotoxicity. Minireview.

  2009cited by this paper
• A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death.

  2009cited by this paper
• Microglial physiology: unique stimuli, specialized responses.

  2009cited by this paper
• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cited by this paper
• Role of microglial IKK b in kainic acid-induced hippocampal neuronal cell death

  2008cited by this paper
• Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression.

  2008cited by this paper
• Inhibitory kappa B kinase-beta is a target for specific nuclear factor kappa B-mediated delayed cardioprotection.

  2008cited by this paper
• Encoding NF-kappaB temporal control in response to TNF: distinct roles for the negative regulators IkappaBalpha and A20.

  2008cited by this paper
• PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways.

  2008cited by this paper
• Role of microglial IKKbeta in kainic acid-induced hippocampal neuronal cell death.

  2008influential reference
• Selective inhibition of NF-κB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease

  2007cited by this paper
• ANP inhibits LPS-induced stimulation of rat microglial cells by suppressing NF-κB and AP-1 activations

  2007cited by this paper
• IKKβ inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury

  2007cited by this paper
• Neuroprotection with pioglitazone against LPS insult on dopaminergic neurons may be associated with its inhibition of NF-kappaB and JNK activation and suppression of COX-2 activity.

  2007cited by this paper
• IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury.

  2007cited by this paper
• Mechanisms of MAPK signalling specificity.

  2006cited by this paper
• Cellular and Molecular Mechanisms of Parkinson’s Disease: Neurotoxins, Causative Genes, and Inflammatory Cytokines

  2006cited by this paper
• ANP inhibits LPS-induced stimulation of rat microglial cells by suppressing NF-kappaB and AP-1 activations.

  2006cited by this paper
• Circuitry of nuclear factor κB signaling

  2006cited by this paper
• Circuitry of nuclear factor kappaB signaling.

  2006cited by this paper
• 3‐Hydroxymorphinan, a metabolite of dextromethorphan, protects nigrostriatal pathway against MPTP‐elicited damage both in vivo and in vitro

  2006influential reference
• The NF-kappaB pathway.

  2005cited by this paper
• TNF-alpha promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway.

  2005cited by this paper
• A selective novel low-molecular-weight inhibitor of IkappaB kinase-beta (IKK-beta) prevents pulmonary inflammation and shows broad anti-inflammatory activity.

  2005cited by this paper
• TNF‐α promotes a stop signal that inhibits neutrophil polarization and migration via a p38 MAPK pathway

  2005cited by this paper
• The NF-κB pathway

  2005cited by this paper
• A selective novel low‐molecular‐weight inhibitor of IκB kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity

  2005cited by this paper
• Spinal NF‐kB activation induces COX‐2 upregulation and contributes to inflammatory pain hypersensitivity

  2004cited by this paper
• IkappaB kinases: key regulators of the NF-kappaB pathway.

  2004cited by this paper
• IκB kinases: key regulators of the NF-κB pathway

  2004cited by this paper
• Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's disease

  2003cited by this paper
• Novel anti-inflammatory therapy for Parkinson's disease.

  2003cited by this paper
• Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons

  2002cited by this paper
• Ligation of CD40 Stimulates the Induction of Nitric-oxide Synthase in Microglial Cells*

  2001influential reference
• Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

  2001cited by this paper
• Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide.

  2000cited by this paper
• Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation.

  2000cited by this paper
• The IKKβ Subunit of IκB Kinase (IKK) is Essential for Nuclear Factor κB Activation and Prevention of Apoptosis

  1999cited by this paper
• How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex.

  1999cited by this paper
• How NF-κB is activated: the role of the IκB kinase (IKK) complex

  1999cited by this paper
• Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

  1997cited by this paper
• Suppression of TNF-α-Induced Apoptosis by NF-κB

  1996cited by this paper
• Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

  1996cited by this paper
• Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

  1988cited by this paper

• MDL800, a SIRT6 activator, mitigates neuroinflammation-induced retinal damage by modulating microglial M1/M2 polarization in experimental glaucoma.

  2025cites this paper
• Dapagliflozin Preserves Peripheral Nerve Structure and Reduces Neuropathic Damage in Streptozotocin-Induced Diabetic Peripheral Neuropathy

  2025cites this paper
• CXCR2 mediates rotenone-induced neuroinflammation and neurodegeneration through neurotrophil infiltration and extracellular traps formation in mice.

  2025cites this paper
• Understanding the link between type 2 diabetes mellitus and Parkinson’s disease: role of brain insulin resistance

  2024cites this paper
• Gallic acid ameliorates LPS-induced memory decline by modulating NF-κB, TNF-α, and Caspase 3 gene expression and attenuating oxidative stress and neuronal loss in the rat hippocampus

  2024cites this paper
• IKKβ Inhibition Attenuates Epithelial Mesenchymal Transition of Human Stem Cell-Derived Retinal Pigment Epithelium

  2023cites this paper
• Why Hypoestoxide is the Ideal Candidate Drug for Disease Modifying Treatment of Parkinson’s Disease

  2023influential citation
• Microglia–neuron–vascular interactions in ischemia

  2023cites this paper
• IκB kinase β (IKKβ): Structure, transduction mechanism, biological function, and discovery of its inhibitors

  2023cites this paper
• Turmeronols (A and B) from Curcuma longa have anti-inflammatory effects in lipopolysaccharide-stimulated BV-2 microglial cells by reducing NF-κB signaling

  2023cites this paper
• Recent research progress on metabolic syndrome and risk of Parkinson’s disease

  2022cites this paper
• Advances in Immunosuppressive Agents Based on Signal Pathway

  2022cites this paper
• Microglia as Therapeutic Target for Radiation-Induced Brain Injury

  2022cites this paper
• Avanafil mediated dual inhibition of IKKβ and TNFR1 in an experimental paradigm of Alzheimer’s disease: in silico and in vivo approach

  2022cites this paper
• Virtual structure-based docking and molecular dynamics of FDA-approved drugs for the identification of potential IKKB inhibitors possessing dopaminergic activity in Alzheimer’s disease

  2022cites this paper
• Neuroprotective and therapeutic effects of calcitriol in rotenone-induced Parkinson’s disease rat model

  2022cites this paper
• The relevant targets of anti-oxidative stress: a review

  2021cites this paper
• The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats.

  2021cites this paper
• Fine Tuning of an Oxidative Stress Model with Sodium Iodate Revealed Protective Effect of NF-κB Inhibition and Sex-Specific Difference in Susceptibility of the Retinal Pigment Epithelium

  2021cites this paper
• Insulin Signaling as a Therapeutic Target in Glaucomatous Neurodegeneration

  2021cites this paper
• Physiological Concentration of H2O2 Supports Dopamine Neuronal Survival via Activation of Nrf2 Signaling in Glial Cells

  2020cites this paper
• The Anti-Inflammatory Effects of Glucagon-Like Peptide Receptor Agonist Lixisenatide on the Retinal Nuclear and Nerve Fiber Layers in an Animal Model of Early Type 2 Diabetes.

  2020cites this paper
• Emodin improves alveolar hypercoagulation and inhibits pulmonary inflammation in LPS-provoked ARDS in mice via NF-κB inactivation.

  2020cites this paper
• Dendrobium nobile Lindl alkaloid attenuates 6‐OHDA‐induced dopamine neurotoxicity

  2020cites this paper
• Targeting MAPK Pathways by Naringenin Modulates Microglia M1/M2 Polarization in Lipopolysaccharide-Stimulated Cultures

  2019cites this paper
• Icariin attenuates neuroinflammation and exerts dopamine neuroprotection via an Nrf2-dependent manner

  2019cites this paper
• Naringenin Produces Neuroprotection Against LPS-Induced Dopamine Neurotoxicity via the Inhibition of Microglial NLRP3 Inflammasome Activation

  2019cites this paper
• Caffeic acid improves locomotor activity and lessens inflammatory burden in a mouse model of rotenone-induced nigral neurodegeneration: Relevance to Parkinson’s disease therapy

  2019cites this paper
• Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation.

  2019cites this paper
• Lipopolysaccharide-Induced Neuroinflammation as a Bridge to Understand Neurodegeneration

  2019cites this paper
• Inhibitory effect of INT‐777 on lipopolysaccharide‐induced cognitive impairment, neuroinflammation, apoptosis, and synaptic dysfunction in mice

  2019cites this paper
• Mechanism underlying β2-AR agonist-mediated phenotypic conversion of LPS-activated microglial cells.

  2019cites this paper
• β-arrestin2 regulates the anti-inflammatory effects of Salmeterol in lipopolysaccharide-stimulated BV2 cells.

  2018cites this paper
• Taurine protects noradrenergic locus coeruleus neurons in a mouse Parkinson’s disease model by inhibiting microglial M1 polarization

  2018cites this paper
• Tetrahydroxystilbene Glucoside Produces Neuroprotection against 6-OHDA-Induced Dopamine Neurotoxicity

  2018cites this paper
• Neutrophil‐Based Drug Delivery Systems

  2018cites this paper
• Icariin Reduces Dopaminergic Neuronal Loss and Microglia-Mediated Inflammation in Vivo and in Vitro

  2018influential citation
• Combination Treatment of Icariin and L-DOPA Against 6-OHDA-Lesioned Dopamine Neurotoxicity

  2018cites this paper
• Dual modulation on glial cells by tetrahydroxystilbene glucoside protects against dopamine neuronal loss

  2018cites this paper
• Damage to dopaminergic neurons by oxidative stress in Parkinson's disease (Review).

  2018cites this paper
• Targeting IKKβ in Cancer: Challenges and Opportunities for the Therapeutic Utilisation of IKKβ Inhibitors

  2018cites this paper
• Interleukin-1 Beta and Tumor Necrosis Factor Alpha Upregulation and Nuclear Factor Kappa B Activation in Skeletal Muscle from a Mouse Model of Chronic/Progressive Parkinson Disease

  2018cites this paper
• Adrenergic Receptors as Pharmacological Targets for Neuroinflammation and Neurodegeneration in Parkinson’s Disease

  2018cites this paper
• Protective role of apigenin on rotenone induced rat model of Parkinson's disease: Suppression of neuroinflammation and oxidative stress mediated apoptosis.

  2017cites this paper
• Investigation of the Nrf2-Mediated inhibition of neuroinflammation by diosgenin

  2017cites this paper
• Adulthood Exposure to Lipopolysaccharide Exacerbates the Neurotoxic and Inflammatory Effects of Rotenone in the Substantia Nigra

  2017cites this paper
• Tetramethylpyrazine Ameliorates Rotenone-Induced Parkinson’s Disease in Rats: Involvement of Its Anti-Inflammatory and Anti-Apoptotic Actions

  2017cites this paper
• Inhibitory effect of punicalagin on lipopolysaccharide‐induced neuroinflammation, oxidative stress and memory impairment via inhibition of nuclear factor‐kappaB

  2017cites this paper
• Benzyl isothiocyanate inhibits inflammasome activation in E. coli LPS-stimulated BV2 cells.

  2016cites this paper
• Inflammation: Role in Parkinson's Disease and Target for Therapy

  2016cites this paper
• In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson's disease which can be attenuated by glycyrrhizin

  2016cites this paper
• The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action.

  2016cites this paper
• Insulin resistance and Parkinson's disease: A new target for disease modification?

  2016cites this paper
• Examining the impact of caspase activities in PD animal model & differentiated ReNcell VM

  2015cites this paper
• Neuroinflammation in the pathophysiology of Parkinson's disease and therapeutic evidence of anti-inflammatory drugs.

  2015cites this paper
• Oxidative Stress, Neuroinflammation, and Neurodegeneration

  2014cites this paper
• Effect of flavonoids on learning, memory and neurocognitive performance: relevance and potential implications for Alzheimer's disease pathophysiology.

  2014cites this paper
• Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)

  2014cites this paper
• A role for human brain pericytes in neuroinflammation

  2014cites this paper
• Polyphénols et neuroprotection: où en sommes-nous aujourd'hui?

  2014cites this paper
• Redox Control of Microglial Function: Molecular Mechanisms and Functional Significance

  2014cites this paper
• Plant Polyphenols as Dietary Modulators of Brain Functions

  2014cites this paper
• The Endotoxin-Induced NeuroinflammationModel of Parkinson ’ s Disease

  2014cites this paper
• Silibinin ameliorates LPS-induced memory deficits in experimental animals.

  2014cites this paper
• Potential neuroprotective actions of dietary flavonoids

  2013cites this paper
• CD11b/CD18 (Mac-1) Is a Novel Surface Receptor for Extracellular Double-Stranded RNA To Mediate Cellular Inflammatory Responses

  2013cites this paper
• The Expression and Release of Hsp60 in 6-OHDA Induced In Vivo and In Vitro Models of Parkinson’s Disease

  2013cites this paper
• β-arrestin protects neurons by mediating endogenous opioid arrest of inflammatory microglia

  2013cites this paper
• Gold-catalyzed oxycyclization of allenic carbamates: expeditious synthesis of 1,3-oxazin-2-ones

  2013cites this paper
• Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease.

  2012cites this paper
• ResponsesRNA To Mediate Cellular Inflammatory Receptor for Extracellular Double-Stranded CD11b/CD18 (Mac-1) Is a Novel Surface

  2012cites this paper
• Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors

  2012cites this paper
• Dietary Polyphenols and Their Effects on Cell Biochemistry and Pathophysiology 2013

  2012cites this paper
• Resveratrol promotes neurotrophic factor release from astroglia

  2012cites this paper
• Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models

  2012cites this paper
• Dietary Polyphenols and Their Effects on Cell Biochemistry and Pathophysiology

  2012cites this paper
• Resveratrol Produces Neurotrophic Effects on Cultured Dopaminergic Neurons through Prompting Astroglial BDNF and GDNF Release

  2012cites this paper
• Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.

  2012cites this paper
• Dietary Polyphenols as Modulators of Brain Functions: Biological Actions and Molecular Mechanisms Underpinning Their Beneficial Effects

  2012cites this paper
• Inflammation in Parkinson’s Disease: Causes and Consequences

  2012cites this paper
• NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

  2012cites this paper
• Oxidative Stress and Microglial Cells in Parkinson's Disease

  2012influential citation
• Inhibitor kappa B kinase beta dependent cytokine upregulation in nociceptive neurons contributes to nociceptive hypersensitivity after sciatic nerve injury.

  2012cites this paper
• Inflammatory Responses and Regulation in Parkinson’s Disease

  2011cites this paper
• Medicinal and Computational Chemistry Dept

  2011cites this paper
• The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease

  2011cites this paper
• HMGB1 Acts on Microglia Mac1 to Mediate Chronic Neuroinflammation That Drives Progressive Neurodegeneration

  2011cites this paper
• The role of IκB kinase complex in the neurobiology of Huntington's disease.

  2011cites this paper
• Nitric Oxide Potentiates TNF-α-Induced Neurotoxicity Through Suppression of NF-κB

  2011cites this paper
• Long-term intraperitoneal injection of lipopolysaccharide induces high expression of Id2 in the brain of mice

  2011cites this paper
• Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia

  2011cites this paper
• Transcriptional Factor NF-κB as a Target for Therapy in Parkinson's Disease

  2011influential citation
• Neuroinflammation is a key player in Parkinson’s disease and a prime target for therapy

  2010cites this paper